| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/31/2007 | WO2007061127A1 Anti-tumor agent for multiple myeloma |
| 05/31/2007 | WO2007060685A1 An improved process for the synthesis of quinoline derivatives |
| 05/31/2007 | WO2007022964A3 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/31/2007 | WO2007017289A3 Acyltryptophanols for fertility control |
| 05/31/2007 | WO2007014941A8 Quinoline derivatives as antibacterial agents |
| 05/31/2007 | WO2006058700A8 Acetamide compounds as fungicides |
| 05/31/2007 | WO2005099688A3 Cyclic compounds |
| 05/31/2007 | US20070123708 Process for the synthesis of quinoline derivatives |
| 05/31/2007 | US20070123705 Alkylation; serotonin receptor antagonists; depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety, sexual dysfunction, bulimia, obesity, addictive disorder |
| 05/31/2007 | US20070123537 Quinazoline derivatives for the treatment of herpesviral infections |
| 05/31/2007 | US20070123493 Benzamide derivative |
| 05/30/2007 | EP1789394A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases |
| 05/30/2007 | EP1789045A2 Chemical compounds |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | CN1970668A Metal salts of quinolinols and quinolinol derivatives as adhesion and conductivity promoters in die attach adhesives |
| 05/30/2007 | CN1318412C Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 05/29/2007 | US7223776 Compounds with anti-bacterial activity |
| 05/29/2007 | US7223774 Benzamide 2-hydroxy-3-diaminoalkanes |
| 05/29/2007 | US7223765 3-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)propan-1-one or salts for example; psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder; high affinity for dopamine D4 receptors |
| 05/29/2007 | US7223761 Salts and polymorphs of a potent antidiabetic compound |
| 05/24/2007 | WO2007058927A1 Histone deacetylase inhibitors as therapeutics for neurological diseases |
| 05/24/2007 | WO2007057228A1 A new intermediate for making montelukast and related compounds |
| 05/24/2007 | WO2007057227A1 Process for making montelukast and intermediates therefor |
| 05/24/2007 | WO2007057225A2 Process for making montelukast and intermediates therefor |
| 05/24/2007 | US20070117983 An organized, self-assembled monolayer (SAM) on a sensing surface of a sensor device for identifying at least one foreign material from environment; has a piezoelectric crystal element and a sensor |
| 05/24/2007 | US20070117978 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same |
| 05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
| 05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 05/24/2007 | CA2629840A1 A new intermediate for making montelukast and related compounds |
| 05/24/2007 | CA2629834A1 Process for making montelukast and intermediates therefor |
| 05/24/2007 | CA2625285A1 Drying methods of montelukast sodium by azeotropic removal of the solvent |
| 05/24/2007 | CA2598093A1 Process for making montelukast and intermediates therefor |
| 05/23/2007 | EP1786823A1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 05/23/2007 | EP1786778A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/23/2007 | EP1786762A2 Amidine substituted aryl aniline compounds |
| 05/23/2007 | EP1562923B1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | EP0907363B1 Medicament comprising (-)-8-[(4-amino-1-méthylbutyl)amino]-5-(3,4-dichlorophénoxy)-6-méthoxy-4-méthylquinoline for the treatment of parasitic and opportunistic infections |
| 05/23/2007 | CN1969205A 滤光片及花青化合物 Filters and anthocyanin compounds |
| 05/23/2007 | CN1968931A Pyridine analogs as C5A antagonists |
| 05/23/2007 | CN1968928A Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 05/23/2007 | CN1968927A Enantioselektive preparation of quinoline derivative |
| 05/22/2007 | US7220884 Hydroaminomethylation of olefins |
| 05/22/2007 | US7220861 Processes for preparing quinolonecarboxylate derivatives |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/22/2007 | US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
| 05/22/2007 | CA2307632C Aqueous liquid pharmaceutical composition |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/18/2007 | WO2007054138A1 Substituted tetrahydroquinolines |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007002635B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 05/18/2007 | WO2006127458A3 Novel chemical compounds |
| 05/18/2007 | WO2006109085A8 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 05/18/2007 | CA2611889A1 Substituted tetrahydroquinolines |
| 05/17/2007 | US20070112024 Crystal form of quinoline compound and process for its production |
| 05/17/2007 | US20070111024 Metal complex compound and organic electroluminescence device containing the same |
| 05/16/2007 | EP1784185A2 Chemical compounds |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315809C Quinoline derivatives and their use as 5-HT6 ligands |
| 05/16/2007 | CN1315808C Olefin monomer of multi-functional group 8-hydroxyquinoline metal complex and its preparation process and application |
| 05/16/2007 | CN1315807C Olefin monomer containing 8-hydroxyquinoline metal complex and its production method and use |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/10/2007 | WO2007052850A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 05/10/2007 | WO2007052849A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 05/10/2007 | WO2007025709A3 Organic compounds |
| 05/10/2007 | WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 05/10/2007 | WO2006127205A3 Methods of preparing 3-cyano-quinolines and intermediates made thereby |
| 05/10/2007 | WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105845 Quinolone derivatives |
| 05/10/2007 | US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases |
| 05/10/2007 | CA2627598A1 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 05/10/2007 | CA2627098A1 Process for the preparation of a leukotriene antagonist and intermediates thereof |
| 05/09/2007 | EP1783117A1 Process for the preparation of a leukotriene antagonist and intermediates thereof |
| 05/09/2007 | EP1781661A2 Vasopressin v1a antagonists |
| 05/09/2007 | EP1781630A1 Novel piperidine derivative for the treatment of depression |
| 05/09/2007 | EP1781615A1 Novel form of a benzenesulfonamide derivative |
| 05/09/2007 | EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 05/09/2007 | EP1401503B1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer |
| 05/09/2007 | CN1960966A Hydrazide-containing CFTR inhibitor compounds and uses thereof |
| 05/09/2007 | CN1958572A Compound in category of dihydro quinolines, preparation method, and composition of medication |
| 05/09/2007 | CN1958568A A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application |
| 05/09/2007 | CN1314671C Olefin monomer containing 8-hydroxyquinoline metal complex and its production method and use |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 05/08/2007 | US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |